Methylglyoxal-derived hydroimidazolone, MG-H1, increases food intake by altering tyramine signaling via the GATA transcription factor ELT-3 in Caenorhabditis elegans

The Maillard reaction, a chemical reaction between amino acids and sugars, is exploited to produce flavorful food almost everywhere, from the baking industry to our everyday life. However, the Maillard reaction also takes place in all cells, from prokaryotes to eukaryotes, leading to the formation of Advanced Glycation End-products (AGEs). AGEs are a heterogeneous group of compounds resulting from the irreversible reaction between biomolecules and α-dicarbonyls (α-DCs), including methylglyoxal (MGO), an unavoidable byproduct of anaerobic glycolysis and lipid peroxidation. We previously demonstrated that Caenorhabditis elegans mutants lacking the glod-4 glyoxalase enzyme displayed enhanced accumulation of α-DCs, reduced lifespan, increased neuronal damage, and touch hypersensitivity. Here, we demonstrate that glod-4 mutation increased food intake and identify that MGO-derived hydroimidazolone, MG-H1, is a mediator of the observed increase in food intake. RNA-seq analysis in glod-4 knockdown worms identified upregulation of several neurotransmitters and feeding genes. Suppressor screening of the overfeeding phenotype identified the tdc-1-tyramine-tyra-2/ser-2 signaling as an essential pathway mediating AGEs (MG-H1) induced feeding in glod-4 mutants. We also identified the elt-3 GATA transcription factor as an essential upstream factor for increased feeding upon accumulation of AGEs by partially regulating the expression of tdc-1 and tyra-2 genes. Further, the lack of either tdc-1 or tyra-2/ser-2 receptors suppresses the reduced lifespan and rescues neuronal damage observed in glod-4 mutants. Thus, in C. elegans, we identified an elt-3 regulated tyramine-dependent pathway mediating the toxic effects of MGO and associated AGEs. Understanding this signaling pathway is essential to modulate hedonistic overfeeding behavior observed in modern AGEs rich diets.

[1]  Nicola Lakeman Future opportunities , 2022, The Veterinary Nurse.

[2]  Joel N. Meyer,et al.  Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans. , 2021, Journal of visualized experiments : JoVE.

[3]  S. Biddle,et al.  Obesity and the risk of developing chronic diseases in middle-aged and older adults: Findings from an Australian longitudinal population survey, 2009–2017 , 2021, PloS one.

[4]  R. Loos,et al.  The genetics of obesity: from discovery to biology , 2021, Nature Reviews Genetics.

[5]  L. Ismail,et al.  Association of risk factors with type 2 diabetes: A systematic review , 2021, Computational and structural biotechnology journal.

[6]  S. Yau,et al.  From Obesity to Hippocampal Neurodegeneration: Pathogenesis and Non-Pharmacological Interventions , 2020, International journal of molecular sciences.

[7]  K. Thakur,et al.  Maillard conjugates and their potential in food and nutritional industries: A review , 2020 .

[8]  Chunyan Tang,et al.  Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Qiaozhi Zhang,et al.  Dietary advanced glycation end-products: Perspectives linking food processing with health implications. , 2020, Comprehensive reviews in food science and food safety.

[10]  M. M. Gromiha,et al.  Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause? , 2020, Frontiers in Neuroscience.

[11]  N. Chondrogianni,et al.  Sugar-derived AGEs accelerate pharyngeal pumping rate and increase the lifespan of Caenorhabditis elegans , 2019, Free radical research.

[12]  P. Vijayagopal,et al.  Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification , 2019, American journal of lifestyle medicine.

[13]  L. K. Sørensen,et al.  ReactELISA method for quantifying methylglyoxal levels in plasma and cell cultures , 2019, Redox biology.

[14]  Michael J. Steinbaugh,et al.  Dietary Restriction Extends Lifespan through Metabolic Regulation of Innate Immunity. , 2019, Cell metabolism.

[15]  Gregory M. Solis,et al.  A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia , 2018, Nature Communications.

[16]  M. Schreiner,et al.  Dietary advanced glycation end products and their relevance for human health , 2018, Ageing Research Reviews.

[17]  Xuguang Zhang,et al.  Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies , 2018, Nutrition & Metabolism.

[18]  P. Kapahi,et al.  The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality. , 2018, Cell metabolism.

[19]  M. Platzer,et al.  Impairing L-Threonine Catabolism Promotes Healthspan through Methylglyoxal-Mediated Proteohormesis. , 2018, Cell metabolism.

[20]  S. Takasawa,et al.  Up-regulation of POMC and CART mRNAs by intermittent hypoxia via GATA transcription factors in human neuronal cells. , 2018, The international journal of biochemistry & cell biology.

[21]  J. Dillon,et al.  Caenorhabditis elegans Feeding Behaviors , 2017 .

[22]  V. De Rosa,et al.  Role of metabolism in neurodegenerative disorders. , 2016, Metabolism: clinical and experimental.

[23]  R. Rumiati,et al.  You stole my food! Eating alterations in frontotemporal dementia , 2016, Neurocase.

[24]  Y. Abed,et al.  Obesity and inflammation: the linking mechanism and the complications , 2016, Archives of medical science : AMS.

[25]  D. Raizen,et al.  Pharyngeal pumping in Caenorhabditis elegans depends on tonic and phasic signaling from the nervous system , 2016, Scientific Reports.

[26]  A. Pandit,et al.  Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans , 2015, Aging cell.

[27]  M. Woodward,et al.  Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? , 2015, The Journal of clinical endocrinology and metabolism.

[28]  P. Magistretti,et al.  Methylglyoxal, the dark side of glycolysis , 2015, Front. Neurosci..

[29]  S. Spencer,et al.  Named Series : Diet , Inflammation and the Brain Obesity and neuroinflammation : A pathway to cognitive impairment , 2014 .

[30]  Paul J Thornalley,et al.  Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples , 2014, Nature Protocols.

[31]  N. Žarković,et al.  Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation , 2013, Free radical research.

[32]  D. Raizen,et al.  Methods for measuring pharyngeal behaviors. , 2012, WormBook : the online review of C. elegans biology.

[33]  Margaret G. Distler,et al.  Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights , 2012, Front. Gene..

[34]  Paul J Thornalley,et al.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy , 2012, Nature Medicine.

[35]  Tao Xu,et al.  Dissecting a central flip-flop circuit that integrates contradictory sensory cues in C. elegans feeding regulation , 2012, Nature Communications.

[36]  M. Hellwig,et al.  Transport of Free and Peptide‐Bound Glycated Amino Acids: Synthesis, Transepithelial Flux at Caco‐2 Cell Monolayers, and Interaction with Apical Membrane Transport Proteins , 2011, Chembiochem : a European journal of chemical biology.

[37]  G. Perry,et al.  Evolutionary adaptations to dietary changes. , 2010, Annual review of nutrition.

[38]  C. Ruhm Understanding Overeating and Obesity , 2012 .

[39]  D. Knorr,et al.  The Maillard reaction and its control during food processing. The potential of emerging technologies. , 2010, Pathologie-biologie.

[40]  G. Colditz,et al.  Obesity and Cancer , 2010, The oncologist.

[41]  Mark J. Alkema,et al.  A Tyramine-Gated Chloride Channel Coordinates Distinct Motor Programs of a Caenorhabditis elegans Escape Response , 2009, Neuron.

[42]  Kaveh Ashrafi,et al.  Neural and molecular dissection of a C. elegans sensory circuit that regulates fat and feeding. , 2008, Cell metabolism.

[43]  H. Hutter,et al.  Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans , 2008, Aging cell.

[44]  R. Baumeister,et al.  A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans. , 2007, Developmental biology.

[45]  M. Koelle,et al.  Biogenic amine neurotransmitters in C. elegans. , 2007, WormBook : the online review of C. elegans biology.

[46]  S. Mango,et al.  The C. elegans pharynx: a model for organogenesis. , 2007, WormBook : the online review of C. elegans biology.

[47]  S. Vannucci,et al.  Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. , 2005, Glycobiology.

[48]  Robert J. Hobson,et al.  TYRA‐2 (F01E11.5): a Caenorhabditis elegans tyramine receptor expressed in the MC and NSM pharyngeal neurons , 2005, Journal of neurochemistry.

[49]  Mark J Alkema,et al.  Tyramine Functions Independently of Octopamine in the Caenorhabditis elegans Nervous System , 2005, Neuron.

[50]  S. Molitor,et al.  Tyramine receptor (SER‐2) isoforms are involved in the regulation of pharyngeal pumping and foraging behavior in Caenorhabditis elegans , 2004, Journal of neurochemistry.

[51]  L. Avery,et al.  LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system. , 2003, Developmental biology.

[52]  B. Wedzicha,et al.  Food chemistry: Acrylamide is formed in the Maillard reaction , 2002, Nature.

[53]  Paul J Thornalley,et al.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.

[54]  J. McGhee,et al.  ELT-3: A Caenorhabditis elegans GATA factor expressed in the embryonic epidermis during morphogenesis. , 1999, Developmental biology.

[55]  S. Mango,et al.  The pha-4 gene is required to generate the pharyngeal primordium of Caenorhabditis elegans. , 1994, Development.

[56]  M. Koelle,et al.  Biogenic amine neurotransmitters in C. , 2007 .

[57]  M. Labouesse [Caenorhabditis elegans]. , 2003, Medecine sciences : M/S.

[58]  L. Istasse,et al.  Maillard reaction : importance and applications in food chemistry , 2002 .

[59]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Maillard,et al.  Action des acides amines sur les sucres : formation des melanoidines par voie methodique , 1912 .